Top Authors

• Most frequent coverage on SSRX

• 
  ChinaBio Today (343 followers)

  • China Biotech in Review: The Business of China Life Science (Sun, Aug 16)
  • China Biotech in Review: Cross Border Collaborations (Mon, Mar 16)
  • 3SBio Reports Higher Sales, Flat Earnings (Fri, Mar 13)

  More by ChinaBio Today on SSRX »
• 
  The Sun (22 followers)

  • China ADRs: Mixed July (Wed, Aug 6)
  • China ADRs: Severe Loss in June (Thu, Jul 3)
  • China ADRs: Mixed May (Thu, Jun 5)

  More by The Sun on SSRX »
• 
  Centient Biotech Investor (10 followers)

  • Biotech Stocks: InterMune Retrenches (Thu, Mar 22)
  • Biotech Week In Review: Flat Never Looked So Good (Mon, Mar 12)
  • Biotech Stocks Day-in-Review: IPOs Heat Up (Thu, Feb 8)

  More by Centient Biotech Investor on SSRX »

• Most followed authors on SSRX

• 
  Bespoke Investment Group (3527 followers)

  • Best, Worst Performing Chinese ADRs YTD (Tue, Oct 23)

  More by Bespoke Investment Group on SSRX »
• 
  Zacks.com (1065 followers)

  • Biotech Opportunities: Look for Decent Pipeline, Big Pharma Partnerships (Tue, Jun 2)
  • 3S Bio: Post-Earnings, Still a Buy (Thu, May 21)

  More by Zacks.com on SSRX »
• 
  SA Editor Miriam Metzinger (539 followers)

  • Jim Cramer's Mad Money Lightning Round, 10/30/07: Buy Dry-Bulk Diana (Wed, Oct 31)

  More by SA Editor Miriam Metzinger on SSRX »

• Newest authors on SSRX

• 
  Kaushik Paul (78 followers)

  • Expect FDA Approval of AMAG Pharmaceutical's Feraheme (Fri, Jun 26)

  More by Kaushik Paul on SSRX »
• 
  Barbara Horne (15 followers)

  • China Rising: CCG's May 18th Chinese Investment Conference (Fri, Jun 12)

  More by Barbara Horne on SSRX »
• 
  David Hunkar (328 followers)

  • The Complete List of Chinese ADR Stocks (Wed, Nov 4)

  More by David Hunkar on SSRX »

• Most commented on SSRX

• 
  The Sun (22 followers)

  • China ADRs: Mixed July (Wed, Aug 6)
  • China ADRs: Severe Loss in June (Thu, Jul 3)
  • China ADRs: Mixed May (Thu, Jun 5)

  More by The Sun on SSRX »
• 
  Kaushik Paul (78 followers)

  • Expect FDA Approval of AMAG Pharmaceutical's Feraheme (Fri, Jun 26)

  More by Kaushik Paul on SSRX »
• 
  Zacks.com (1065 followers)

  • Biotech Opportunities: Look for Decent Pipeline, Big Pharma Partnerships (Tue, Jun 2)
  • 3S Bio: Post-Earnings, Still a Buy (Thu, May 21)

  More by Zacks.com on SSRX »